April 10, 2019 / 4:24 AM / 6 months ago

BUZZ-India healthcare: Nomura expects a healthy Q4

** Nomura expects a healthy Q4 for Indian healthcare and pharmaceuticals sector

** It sees revenue growth at 11 pct year-on-year in Q4; EBITDA and net earnings likely to witness record growth of 17 pct and 8 pct, respectively

** Prescription volumes have increased for most India companies year-on-year as they gained market share, Nomura said in a note

** Brokerage expects mid-teens growth in revenues for diagnostics sector and steady improvement quarter-on-quarter in volumes and EBITDA margins for hospitals

** Lupin Ltd, IPCA Laboratories Ltd, Apollo Hospitals Enterprise Ltd could see investors’ interest in the near term as we expect their results/outlook commentaries to surprise the street on the upside - Nomura

** The Nifty Pharma Index up 0.26 pct in early trading on Wednesday; up 5.24 pct this year as of last close

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below